Repositioning Candidates
Repositioning candidates for CKD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and CKD-associated disease in CKDdb are presented with knowledge graphs.
stats1
stats2
stats3
Search for:
anti-inflammatory12 records.
| Candidate ID | Source ID | Source Type | Compound Type | Candidate Name | Inclusion Criteria | |
|---|---|---|---|---|---|---|
| R0001 | DB00007 | approved; investigational | small molecule | Leuprolide | Details | |
| R0010 | DB00125 | investigational; nutraceutical | small molecule | Arginine | Details | |
| R0046 | DB00188 | approved; investigational | small molecule | Bortezomib | Details | |
| R0066 | DB00254 | approved; investigational; vet_approved | small molecule | Doxycycline | Details | |
| R0082 | DB00310 | approved | small molecule | Chlorthalidone | Details | |
| R0121 | DB00425 | approved | small molecule | Zolpidem | Details | |
| R0134 | DB00479 | approved; investigational; vet_approved | small molecule | Amikacin | Details | |
| R0135 | DB00480 | approved | small molecule | Lenalidomide | Details | |
| R0172 | DB00607 | approved; investigational | small molecule | Nafcillin | Details | |
| R0179 | DB00627 | approved; investigational; nutraceutical | small molecule | Niacin | Details | |
| R0196 | DB00684 | approved; investigational | small molecule | Tobramycin | Details | |
| R0202 | DB00704 | approved; investigational; vet_approved | small molecule | Naltrexone | Details |